Atteinte vasculaire et remodelage ventriculaire gauche dans la maladie de Fabry

Pierre Boutouyrie; Elie Mousseaux; Benjamin Cocheteux; Stéphane Laurent; Dominique P. Germain

doi:10.1051/medsci/20052111s30

Accueil

Tous les numéros

Volume 21 (Décembre 2005) Numéro spécial

Med Sci (Paris), 21 (2005) 30-32

Références

Accès gratuit

Numéro		Med Sci (Paris) Volume 21, Décembre 2005 Métabolisme glucidolipidique et risque cardiovasculaire: Nouvelle approches


Page(s)		30 - 32
Section		M/S revues
DOI		https://doi.org/10.1051/medsci/20052111s30
Publié en ligne		15 novembre 2005

MacDermot KD, Holmes A, Miners AH. Anderson-Fabry disease: clinical manifestations and impact of disease in a cohort of 60 obligate carrier females. J Med Genet 2001; 38 : 769–75. [Google Scholar]
MacDermot KD, Holmes A, Miners AH. Anderson-Fabry disease: clinical manifestations and impact of disease in a cohort of 98 hemizygous males. J Med Genet 2001; 38 : 750–60. [Google Scholar]
Germain DP. Fabry’s disease (alpha-galactosidase-A deficiency): physiopathology, clinical signs, and genetic aspects. J Soc Biol 2002; 196 : 161–73. [Google Scholar]
Boutouyrie P, Laurent S, Laloux B, et al. Arterial remodelling in Fabry disease. Acta Paediatr 2002; 91 (suppl): 62–6. [Google Scholar]
Boutouyrie P, Laurent S, Laloux B, et al. Non-invasive evaluation of arterial involvement in patients affected with Fabry disease. J Med Genet 2001; 38 : 629–31. [Google Scholar]
Elleder M, Bradova V, Smid F, et al. Cardiocyte storage and hypertrophy as a sole manifestation of Fabry’s disease. Report on a case simulating hypertrophic non-obstructive cardiomyopathy. Virchows Arch A Pathol Anat Histopathol 1990; 417 : 449–55. [Google Scholar]
Desnick RJ, Blieden LC, Sharp HL, et al. Cardiac valvular anomalies in Fabry disease. Clinical, morphologic, and biochemical studies. Circulation 1976; 54 : 818–25. [Google Scholar]
Chatterjee S. Sphingolipids in atherosclerosis and vascular biology. Arterioscler Thromb Vasc Biol 1998; 18: 1523–33. [Google Scholar]
Saba PS, Roman MJ, Pini R, et al. Relation of arterial pressure waveform to left ventricular and carotid anatomy in normotensive subjects. J Am Coll Cardiol 1993; 22 : 1873–80. [Google Scholar]
Ganau A, Devereux RB, Roman MJ, et al. Patterns of left ventricular hypertrophy and geometric remodeling in essential hypertension. J Am Coll Cardiol 1992; 19 : 1550–8. [Google Scholar]
Boutouyrie P, Laurent S, Girerd X, et al. Common carotid artery stiffness and patterns of left ventricular hypertrophy in hypertensive patients. Hypertension 1995; 25 : 651–9. [Google Scholar]
Fisher EA, Desnick RJ, Gordon RE, et al. Fabry disease: an unusual cause of severe coronary disease in a young man. Ann Intern Med 1992; 117 : 221–3. [Google Scholar]
Linhart A, Palecek T, Bultas J, et al. New insights in cardiac structural changes in patients with Fabry’s disease. Am Heart J 2000; 139 : 1101–8. [Google Scholar]

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.

[1] MacDermot KD, Holmes A, Miners AH. Anderson-Fabry disease: clinical manifestations and impact of disease in a cohort of 60 obligate carrier females. J Med Genet 2001; 38 : 769–75. [Google Scholar]

[2] MacDermot KD, Holmes A, Miners AH. Anderson-Fabry disease: clinical manifestations and impact of disease in a cohort of 98 hemizygous males. J Med Genet 2001; 38 : 750–60. [Google Scholar]

[3] Germain DP. Fabry’s disease (alpha-galactosidase-A deficiency): physiopathology, clinical signs, and genetic aspects. J Soc Biol 2002; 196 : 161–73. [Google Scholar]

[4] Boutouyrie P, Laurent S, Laloux B, et al. Arterial remodelling in Fabry disease. Acta Paediatr 2002; 91 (suppl): 62–6. [Google Scholar]

[5] Boutouyrie P, Laurent S, Laloux B, et al. Non-invasive evaluation of arterial involvement in patients affected with Fabry disease. J Med Genet 2001; 38 : 629–31. [Google Scholar]

[6] Elleder M, Bradova V, Smid F, et al. Cardiocyte storage and hypertrophy as a sole manifestation of Fabry’s disease. Report on a case simulating hypertrophic non-obstructive cardiomyopathy. Virchows Arch A Pathol Anat Histopathol 1990; 417 : 449–55. [Google Scholar]

[7] Desnick RJ, Blieden LC, Sharp HL, et al. Cardiac valvular anomalies in Fabry disease. Clinical, morphologic, and biochemical studies. Circulation 1976; 54 : 818–25. [Google Scholar]

[8] Chatterjee S. Sphingolipids in atherosclerosis and vascular biology. Arterioscler Thromb Vasc Biol 1998; 18: 1523–33. [Google Scholar]

[9] Saba PS, Roman MJ, Pini R, et al. Relation of arterial pressure waveform to left ventricular and carotid anatomy in normotensive subjects. J Am Coll Cardiol 1993; 22 : 1873–80. [Google Scholar]

[10] Ganau A, Devereux RB, Roman MJ, et al. Patterns of left ventricular hypertrophy and geometric remodeling in essential hypertension. J Am Coll Cardiol 1992; 19 : 1550–8. [Google Scholar]

[11] Boutouyrie P, Laurent S, Girerd X, et al. Common carotid artery stiffness and patterns of left ventricular hypertrophy in hypertensive patients. Hypertension 1995; 25 : 651–9. [Google Scholar]

[12] Fisher EA, Desnick RJ, Gordon RE, et al. Fabry disease: an unusual cause of severe coronary disease in a young man. Ann Intern Med 1992; 117 : 221–3. [Google Scholar]

[13] Linhart A, Palecek T, Bultas J, et al. New insights in cardiac structural changes in patients with Fabry’s disease. Am Heart J 2000; 139 : 1101–8. [Google Scholar]